Logo image of AVYA

AVAYA HOLDINGS CORP (AVYA) Stock Fundamental Analysis

USA - NYSE:AVYA - US05351X1019 - Common Stock

0.2753 USD
-0.03 (-10.73%)
Last: 2/13/2023, 8:08:44 PM
0.29 USD
+0.01 (+5.34%)
Pre-Market: 2/14/2023, 8:01:50 AM
Fundamental Rating

2

AVYA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. AVYA has a bad profitability rating. Also its financial health evaluation is rather negative. AVYA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AVYA was profitable.
AVYA had a negative operating cash flow in the past year.
AVYA Yearly Net Income VS EBIT VS OCF VS FCFAVYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B 2B 3B

1.2 Ratios

The profitability ratios for AVYA are negative, so there is not much use analyzing them.
AVYA has a better Return On Invested Capital (0.23%) than 73.33% of its industry peers.
AVYA had an Average Return On Invested Capital over the past 3 years of 76.09%. This is significantly above the industry average of 11.76%.
The 3 year average ROIC (76.09%) for AVYA is well above the current ROIC(0.23%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 0.23%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)76.09%
ROIC(5y)N/A
AVYA Yearly ROA, ROE, ROICAVYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 100 -100

1.3 Margins

AVYA has a Operating Margin of 0.33%. This is in the better half of the industry: AVYA outperforms 73.00% of its industry peers.
AVYA's Operating Margin has declined in the last couple of years.
AVYA has a worse Gross Margin (51.12%) than 67.67% of its industry peers.
AVYA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.33%
PM (TTM) N/A
GM 51.12%
OM growth 3Y222.57%
OM growth 5Y-4.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.68%
GM growth 5Y-1.76%
AVYA Yearly Profit, Operating, Gross MarginsAVYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60 80 100

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), AVYA is creating value.
AVYA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AVYA has a worse debt to assets ratio.
AVYA Yearly Shares OutstandingAVYA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M
AVYA Yearly Total Debt VS Total AssetsAVYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -0.09, we must say that AVYA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.09, AVYA is doing worse than 71.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACC0.04
WACC5.23%
AVYA Yearly LT Debt VS Equity VS FCFAVYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 2B -2B 4B -4B 6B

2.3 Liquidity

A Current Ratio of 1.18 indicates that AVYA should not have too much problems paying its short term obligations.
AVYA's Current ratio of 1.18 is on the low side compared to the rest of the industry. AVYA is outperformed by 72.00% of its industry peers.
AVYA has a Quick Ratio of 1.14. This is a normal value and indicates that AVYA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.14, AVYA is not doing good in the industry: 72.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.14
AVYA Yearly Current Assets VS Current LiabilitesAVYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

More info and screens

0

3. Growth

3.1 Past

AVYA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.78%.
AVYA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.24% yearly.
AVYA shows a decrease in Revenue. In the last year, the revenue decreased by -6.81%.
The Revenue has been decreasing by -4.29% on average over the past years.
EPS 1Y (TTM)-59.78%
EPS 3Y-14.24%
EPS 5YN/A
EPS Q2Q%-132%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y1.41%
Revenue growth 5Y-4.29%
Sales Q2Q%-21.17%

3.2 Future

The Earnings Per Share is expected to decrease by -43.37% on average over the next years. This is quite bad
AVYA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.09% yearly.
EPS Next Y-85.74%
EPS Next 2Y-42.17%
EPS Next 3Y-43.37%
EPS Next 5YN/A
Revenue Next Year-11.4%
Revenue Next 2Y-7.96%
Revenue Next 3Y-5.09%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AVYA Yearly Revenue VS EstimatesAVYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
AVYA Yearly EPS VS EstimatesAVYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 0 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.19 indicates a rather cheap valuation of AVYA.
Compared to the rest of the industry, the Price/Earnings ratio of AVYA indicates a rather cheap valuation: AVYA is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AVYA to the average of the S&P500 Index (27.38), we can say AVYA is valued rather cheaply.
AVYA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.19
Fwd PE N/A
AVYA Price Earnings VS Forward Price EarningsAVYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVYA is valued cheaply inside the industry as 96.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.09
AVYA Per share dataAVYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

A cheap valuation may be justified as AVYA's earnings are expected to decrease with -43.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.17%
EPS Next 3Y-43.37%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVYA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVAYA HOLDINGS CORP

NYSE:AVYA (2/13/2023, 8:08:44 PM)

Premarket: 0.29 +0.01 (+5.34%)

0.2753

-0.03 (-10.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-13 2023-02-13/amc
Earnings (Next)05-08 2023-05-08/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.25%
Ins Owner Change0%
Market Cap23.91M
Analysts44.44
Price Target0.65 (136.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-0.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-276.28%
Min EPS beat(2)-537.11%
Max EPS beat(2)-15.45%
EPS beat(4)1
Avg EPS beat(4)-146.72%
Min EPS beat(4)-537.11%
Max EPS beat(4)5.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.95%
Min Revenue beat(2)-9.02%
Max Revenue beat(2)-4.88%
Revenue beat(4)1
Avg Revenue beat(4)-4.51%
Min Revenue beat(4)-9.02%
Max Revenue beat(4)0.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-35.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.19
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 6.09
EPS(TTM)1.48
EY537.6%
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-2.74
FCFYN/A
OCF(TTM)-2.34
OCFYN/A
SpS31.85
BVpS-9.17
TBVpS-34.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 0.23%
ROICexc 0.25%
ROICexgc 1.01%
OM 0.33%
PM (TTM) N/A
GM 51.12%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)76.09%
ROIC(5y)N/A
ROICexc(3y)3.53%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y260.08%
ROICexc growth 5YN/A
OM growth 3Y222.57%
OM growth 5Y-4.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.68%
GM growth 5Y-1.76%
F-Score2
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.14
Altman-Z -0.09
F-Score2
WACC5.23%
ROIC/WACC0.04
Cap/Depr(3y)25.09%
Cap/Depr(5y)22.24%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.78%
EPS 3Y-14.24%
EPS 5YN/A
EPS Q2Q%-132%
EPS Next Y-85.74%
EPS Next 2Y-42.17%
EPS Next 3Y-43.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y1.41%
Revenue growth 5Y-4.29%
Sales Q2Q%-21.17%
Revenue Next Year-11.4%
Revenue Next 2Y-7.96%
Revenue Next 3Y-5.09%
Revenue Next 5YN/A
EBIT growth 1Y-96.27%
EBIT growth 3Y227.11%
EBIT growth 5Y-8.7%
EBIT Next Year-32.7%
EBIT Next 3Y-6.79%
EBIT Next 5YN/A
FCF growth 1Y-666.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-241.96%
OCF growth 3YN/A
OCF growth 5Y-23.3%